Andreas Reif
Heinrich Hoffmann Str. 10
Frankfurt Am Main, HE 60528, Germany
Frankfurt Am Main, HE 60528, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 598 publications
Erratum to "Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study" [European Neuropsychopharmacology 107 (2026) 112801].
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: August 27, 2026
Precision medicine in mental health: applications, challenges, and recommendations - CORRIGENDUM.
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: June 29, 2026
Frequency and Correlates of Inaccurate Psychiatric Diagnoses in 401 Adults Hospitalized for Major Depressive Disorder: A Comparison of Clinical vs. Research Interview-Based Diagnoses.
Journal: CNS spectrums
Published: June 09, 2026
Efficacy of an Unguided Digital Intervention for Adults With Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial.
Journal: Deutsches Arzteblatt international
Published: June 04, 2026
Epidemiology of aggression and violence in mental disorders and the approach of TRR 379.
Journal: Der Nervenarzt
Published: May 27, 2026
Response to: Commentary on "Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study".
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: May 22, 2026
Precision medicine in mental health: applications, challenges, and recommendations.
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: April 27, 2026
The cost-effectiveness of predictive algorithm guided primary antidepressant treatment: economic evaluation of the multinational PReDicT randomised controlled trial.
Journal: BJPsych open
Published: April 13, 2026
Transcutaneous vagus nerve stimulation enhances reward-effort efficiency in severe major depressive disorder.
Journal: Journal of affective disorders
Published: April 01, 2026
Last Updated: 09/26/2026